Michael Manolakis News Today

New weight loss drugs, such as Novo Nordisk’s Ozempic and Wegovy (semaglutide) and Eli Lilly’s Mounjaro (tirzepatide), could be transformative for people who struggle with obesity and obesity-related medical conditions, but there are major questions to consider related to insurance coverage, the cost of the drugs, and who has access. Importantly, by law, the drugs<span class="readmore-ellipsis">…</span><a href="https://www.kff.org/medicare/event/august-4-...

"These are revolutionary drugs."

While many large employers have been covering weight-loss drugs, Wegovy's high price and the huge increase in people taking it has them reconsidering that.

Shawnte struggled with her weight for years before she was prescribed Novo Nordisk’s diabetes drug Ozempic for weight loss in 2020, helping the former music industry professional from New York lose more than 50 pounds over two years. But last year, the 46-year-old, who asked to be identified only by her first name to protect her privacy, was told her health insurance would not cover her weight loss treatment. The health insurance plan, which Shawnte's husband received through his j...

By Patrick Wingrove (Reuters) - Shawnte struggled with her weight for years before she was prescribed Novo Nordisk's diabetes drug Ozempic for weight ...